The following is a Congressional letter from a group of healthcare and patient advocacy organizations asking Senate and House Leadership to “prioritize access to emerging precision medicine tools for autoimmune diseases. Emerging innovations within the field of precision medicine, including predictive drug response tests, aim to address this challenge by using the patient's unique biology to drive treatment decisions.”
